PT957935E - Vacinas e composicoes imunogenicas contra clamidia contendo um antigenio de membrana externa e metodos para a sua preparacao - Google Patents

Vacinas e composicoes imunogenicas contra clamidia contendo um antigenio de membrana externa e metodos para a sua preparacao

Info

Publication number
PT957935E
PT957935E PT97939910T PT97939910T PT957935E PT 957935 E PT957935 E PT 957935E PT 97939910 T PT97939910 T PT 97939910T PT 97939910 T PT97939910 T PT 97939910T PT 957935 E PT957935 E PT 957935E
Authority
PT
Portugal
Prior art keywords
membrane antigen
chlamydia
clamidia
preparation
methods
Prior art date
Application number
PT97939910T
Other languages
English (en)
Inventor
Andrew D Murdin
Brian J Underdown
Original Assignee
Aventis Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pasteur filed Critical Aventis Pasteur
Publication of PT957935E publication Critical patent/PT957935E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
PT97939910T 1996-09-12 1997-09-11 Vacinas e composicoes imunogenicas contra clamidia contendo um antigenio de membrana externa e metodos para a sua preparacao PT957935E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/713,236 US6464979B1 (en) 1996-09-12 1996-09-12 Chlamydial vaccines and methods of preparation thereof

Publications (1)

Publication Number Publication Date
PT957935E true PT957935E (pt) 2003-08-29

Family

ID=24865335

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97939910T PT957935E (pt) 1996-09-12 1997-09-11 Vacinas e composicoes imunogenicas contra clamidia contendo um antigenio de membrana externa e metodos para a sua preparacao

Country Status (10)

Country Link
US (2) US6464979B1 (pt)
EP (1) EP0957935B1 (pt)
AT (1) ATE234630T1 (pt)
AU (1) AU4195897A (pt)
CA (1) CA2280037A1 (pt)
DE (1) DE69720056T2 (pt)
DK (1) DK0957935T3 (pt)
ES (1) ES2195169T3 (pt)
PT (1) PT957935E (pt)
WO (1) WO1998010789A1 (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6258532B1 (en) 1997-08-14 2001-07-10 Vanderbilt University Methods for in vitro susceptibility testing of chlamydia
US6710033B1 (en) 1996-08-14 2004-03-23 Vanderbilt University Methods and treatment of multiple sclerosis
US6890526B2 (en) 1997-05-06 2005-05-10 Vanderbilt University Methods and reagents for the treatment of multiple sclerosis
US7459524B1 (en) 1997-10-02 2008-12-02 Emergent Product Development Gaithersburg Inc. Chlamydia protein, sequence and uses thereof
AU772356B2 (en) * 1998-12-04 2004-04-22 Aventis Pasteur Limited Two-step immunization procedure against chlamydia infection
KR20100132086A (ko) * 1998-12-08 2010-12-16 코릭사 코포레이션 클라미디아 감염을 치료 및 진단하기 위한 조성물 및 이를 포함하는 약제학적 조성물 및 진단 키트
US6565856B1 (en) 1998-12-08 2003-05-20 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US20020061848A1 (en) 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
US6432916B1 (en) 1998-12-08 2002-08-13 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US6447779B1 (en) 1998-12-08 2002-09-10 Corixa Corporation Compounds for the diagnosis of Chlamydial infection
US6555115B1 (en) 1998-12-08 2003-04-29 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US6448234B1 (en) 1998-12-08 2002-09-10 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
AU3760400A (en) * 1999-03-19 2000-10-09 Vanderbilt University Methods and reagents for the diagnosis and treatment of multiple sclerosis
DE19939246A1 (de) * 1999-08-19 2001-02-22 Phasys Gmbh M Rückfaltung von Membranproteinen
DE60044146D1 (de) * 1999-12-22 2010-05-20 Aventis Pasteur D ihre verwendungen
US20010048927A1 (en) 2000-02-01 2001-12-06 Richard Stephens Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia
GB0003217D0 (en) * 2000-02-11 2000-04-05 Yaba Ltd Invention
US6919187B2 (en) 2000-04-21 2005-07-19 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
EP1278855B1 (en) 2000-04-21 2008-03-12 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
AUPQ954000A0 (en) * 2000-08-18 2000-09-14 Queensland University Of Technology Novel diagnostic agents and uses therefor
US20030138434A1 (en) * 2001-08-13 2003-07-24 Campbell Robert L. Agents for enhancing the immune response
US7105171B2 (en) 2002-03-07 2006-09-12 The Regents Of The University Of California Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
TWI341836B (en) * 2004-03-11 2011-05-11 Theravance Inc Biphenyl compounds useful as muscarinic receptor antagonists
ES2325243B1 (es) * 2008-02-27 2011-05-04 Universidad De Granada Antigeno recombinante.
EP2413959A4 (en) 2009-01-29 2013-06-19 British Columbia Cancer Agency CHLAMYDIA-ANTIGENE COMPREHENSIVE COMPOSITIONS
CN103068837B (zh) 2010-05-28 2015-06-24 斯匹遐生物技术公司 嵌合momp抗原、方法和使用
AR132053A1 (es) 2023-03-02 2025-05-21 Sanofi Pasteur Composiciones para su uso en el tratamiento de clamidia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4427782A (en) * 1981-03-03 1984-01-24 Caldwell Harlan D Isolation of principal outer membrane protein and antigen of Chlamydia trachomatis
GB8919819D0 (en) * 1989-09-01 1989-10-18 Coopers Animal Health Complexes having adjuvant activity

Also Published As

Publication number Publication date
US6635746B1 (en) 2003-10-21
DE69720056D1 (de) 2003-04-24
EP0957935B1 (en) 2003-03-19
ATE234630T1 (de) 2003-04-15
DE69720056T2 (de) 2003-10-30
EP0957935A1 (en) 1999-11-24
AU4195897A (en) 1998-04-02
ES2195169T3 (es) 2003-12-01
WO1998010789A1 (en) 1998-03-19
DK0957935T3 (da) 2003-06-23
CA2280037A1 (en) 1998-03-19
US6464979B1 (en) 2002-10-15

Similar Documents

Publication Publication Date Title
PT957935E (pt) Vacinas e composicoes imunogenicas contra clamidia contendo um antigenio de membrana externa e metodos para a sua preparacao
ES2176232T3 (es) Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter.
BR9811475A (pt) Conjugados imunogênicos compreendendo uma porina meningocóccica de grupo b e um polissacarìdeo de h. influenzae
DK0696297T3 (da) Pyridobisimidazolbaseret stiv stavpolymer
WO1997001640A3 (en) Vaccines against hepatitis c
ATE229978T1 (de) Helicobacter proteine und impstoffe
ATE264911T1 (de) Eine universelle immunmodulatorische cytokin- expressierende zelllinie in wartestelling. entsprechende zusammensetzungen und methoden ihrer herstellung und verwendungen
EP0370573A3 (en) Skin test and test kit for aids
BRPI0009163B8 (pt) composição imunogênica e vacina que a compreende
CA2187974A1 (en) Newcastle disease virus combination vaccine
EP1946773A3 (en) Improved saponin adjuvant compositions and methods relating thereto
EP0841941A4 (en) Novel non-pyrogenic bacterial strains and their use
TW347335B (en) Solid silicone compositions and methods for their preparation and use
CA2333601A1 (en) Surfactant for use in external preparations for skin and external preparation for skin containing the same
NO974727D0 (no) Immunogene og immunostimulatoriske oligosakkarid sammensetninger og fremgangsmåter for fremstilling derav
CA2093513A1 (en) Methods and compositions for suppressing allograft rejection in mammals
PT854924E (pt) Antigenios de leishmania para uso na terapia e diagnostico da leishmaniose
ES2137310T3 (es) Vacuna contra una infeccion por streptococcus suis.
BR0111834A (pt) Composições adjuvante e imunogênica, e, método para eliciar uma resposta imune a um antìgeno
MX9207605A (es) Composicion farmaceutica que contiene glucosidos de antraciclina unidos a un derivado polimerico y metodo para preparar la misma.
FI972054A0 (fi) Immunogeenisiä koostumuksia
WO2002034287A3 (en) Therapeutic vaccine formulations containing chitosan
ES2106032T3 (es) Vacuna para inmunizar gatos contra el desprendimiento de oocistos de toxoplasma.
DE69207777D1 (de) Körperpflegemittel
BR9814958B1 (pt) Proteína de cimento de tecido, composição farmacêutica, uso da proteína de cimento de tecido, vacina, processos para produção de vacina, para ligação de tecido de animal e para preparação de uma protéina de cimento de tecido